TissueGene Inc (950160)

KOSDAQ

Currency in KRW

950160 Pro Research

19,330

+1,670(+9.46%)

Closed·02:29:59

Fair Value

Unlock Value

Day's Range

17,740

20,700

52 wk Range

11,470

149,000

950160 Financial Summary

A brief financial summary of TissueGene Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-29.68

Price/Book68.49

Debt / Equity52.06%

Return on Equity-185.81%

Dividend Yield0.00%

EBITDA-21.54B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Income Statement

Total Revenues

aa.aa

4,003.15

9,456.04

3,706.06

5,073.44

5,158.71

Gross Profit

aa.aa

392.15

7,645.27

365.92

545.13

614.5

Operating Income

aa.aa

-47,100.59

-16,307.73

-20,511.15

-21,997.69

-22,323.13

Net Income

aa.aa

-47,369.61

-11,136.21

-17,224.37

-33,798.81

-192,587.48

Balance Sheet

Total Assets

aa.aa

61,399.48

109,889.9

134,910.38

222,288.12

423,990.24

Total Current Liabilities

aa.aa

16,142.91

11,603.67

14,303.35

71,110.72

355,681.56

Total Equity

aa.aa

38,647.73

91,488.73

114,963.38

145,903.68

64,081

Cash Flow

Levered Free Cash Flow

aa.aa

-25,649.23

-38,159.09

-54,982.82

-46,514.76

92,842.55

Cash from Operations

aa.aa

-40,019.93

-26,775.63

-24,109.06

-20,451.72

-24,014.06

Cash from Investing

aa.aa

33,418.66

-40,056.64

-29,039.48

-77,245.34

-131,648.7

Cash from Financing

aa.aa

24,581.88

66,909.45

38,102.42

69,468.31

222,058.36

Net Change in Cash

aa.aa

17,985.7

72.76

-15,039.48

-28,274.28

66,366.82

* In Millions of KRW (except for per share items)

Analyst Ratings

1 Buy

0 Hold

0 Sell

Ratings:

1 analysts

Overall Consensus

Strong Buy

Analysts 12-Month Price Target:

Average 150,000

(+676.00% Upside)

Earnings

Latest Release

May 15, 2026

EPS / Forecast

-1,200.00 / -60.00

Revenue / Forecast

1.41B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were TissueGene's earnings for the latest quarter?

The TissueGene EPS (TTM) is -3,457. TissueGene reported sales of 1,410, net income of -99,878, and EPS of -1,200 for the latest quarter.

What was TissueGene's net income for the latest quarter?

TissueGene's net income for the latest quarter was -99,878.

How did TissueGene's performance compare year-over-year in the latest quarter?

The company's revenue moved from 861 million KRW in the previous quarter to 1,410 million KRW in the latest quarter, and net income moved from -123,926 million KRW to -99,878 million KRW compared to the previous quarter.

What is TissueGene's net profit margin on a TTM basis?

TissueGene's trailing twelve months (TTM) net profit margin is -5,428%.

How does TissueGene's debt to equity ratio compare to industry standards?

TissueGene's total debt-to-equity ratio is 52%.

What is TissueGene's return on investment on a TTM basis?

TissueGene's trailing twelve months (TTM) return on investment (ROI) is -186%.

How has TissueGene's total revenue grown this year?

TissueGene's total revenue was 861 million KRW in the previous quarter and 1,410 million KRW in the latest quarter.

What is TissueGene's gross margin on a TTM basis?

TissueGene's trailing twelve months (TTM) gross margin is 12%%.

What was TissueGene's revenue per share for the latest quarter?

TissueGene's revenue per share for the latest quarter was 1,478.

S&P/TSX

36,381.23

+244.92

+0.68%

S&P/TSX 60

2,139.10

+7.23

+0.34%

US 30

53,989.90

-46.6

-0.09%

US 500

7,768.30

+10.8

+0.14%

S&P 500 VIX

15.47

+0.57

+3.83%

DAX

26,393.34

+37.99

+0.14%

Dollar Index

99.532

+0.109

+0.11%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.55	-1.17%	13.15M
RBC	294.59	-0.66%	2.65M
Bank of Montreal	253.24	-0.09%	2.59M
Shopify Inc	211.37	+2.40%	3.06M
Toronto Dominion Bank	169.30	-0.39%	3.79M
Suncor Energy	83.83	-2.57%	7.05M
Barrick Mining	60.96	+4.96%	8.30M

Name	Last	Chg. %	Vol.
1933 Industries	0.01	+200.00%	692.50K
FuelPositive	0.070	+133.33%	2.26M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
James Bay Resources Ltd	0.020	+100.00%	1.47K
Digicann Ventures	0.010	+100.00%	2.00K
ePlay Digital	0.010	+100.00%	7.00K
1933 Industries	0.0100	+100.00%	692.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	10.15K
Big Bear Gold	0.07	-78.33%	15.00K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Albert Labs International	0.005	-50.00%	1.00K
Champion Electric	0.005	-50.00%	39.00K
International Iconic Gold Exploration	0.0050	-50.00%	276.00K
Red Lake Gold	0.0050	-50.00%	51.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	443.51	+0.19%	541.78K
Keel Infra	5.40	+0.93%	1.95M
Equinox Gold	16.16	+7.16%	7.24M
Canadian Natural	63.45	-0.60%	7.10M
Hut 8	123.440	-3.14%	533.96K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaaaa	2.860	+58.57%	4.535
Aaaa Aaaaa	34.74	+55.48%	54.01
A Aa A Aa Aaaaaa	104.38	+52.02%	158.68
Aaaaaaa Aaaaaa	8.70	+48.66%	12.93
A Aaaa Aaaa	142.78	+46.11%	208.62
Aa Aaaaaaaaaaaaaaaaa	5.31	+45.40%	7.72
A Aaa Aaa	4.75	+41.65%	6.73

Name	Last	Upside	Fair Value
A Aaaaaaa	2.860	+58.57%	4.535
Aaaa Aaaaa	34.74	+55.48%	54.01
A Aa A Aa Aaaaaa	104.38	+52.02%	158.68
Aaaaaaa Aaaaaa	8.70	+48.66%	12.93
A Aaaa Aaaa	142.78	+46.11%	208.62
Aa Aaaaaaaaaaaaaaaaa	5.31	+45.40%	7.72
A Aaa Aaa	4.75	+41.65%	6.73

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

TissueGene Inc (950160)

950160 Financial Summary

Key Ratios

Statements Highlights

Analyst Ratings

Analysts 12-Month Price Target:

Earnings

FAQ

What were TissueGene's earnings for the latest quarter?

What was TissueGene's net income for the latest quarter?

How did TissueGene's performance compare year-over-year in the latest quarter?

What is TissueGene's net profit margin on a TTM basis?

How does TissueGene's debt to equity ratio compare to industry standards?

What is TissueGene's return on investment on a TTM basis?

How has TissueGene's total revenue grown this year?

What is TissueGene's gross margin on a TTM basis?

What was TissueGene's revenue per share for the latest quarter?

Trending Stocks